A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. [electronic resource]
Producer: 20140512Description: 1015-1025 p. digitalISSN:- 1940-6215
- Adenocarcinoma -- drug therapy
- Administration, Oral
- Animals
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis
- Aspirin -- administration & dosage
- Carcinogens -- chemistry
- Cell Line, Tumor
- Cricetinae
- Curcumin -- administration & dosage
- Disease Models, Animal
- Disease Progression
- Drug Delivery Systems
- Immunohistochemistry
- In Situ Nick-End Labeling
- Isothiocyanates -- administration & dosage
- Lipids -- chemistry
- Male
- Mesocricetus
- Nanoparticles -- chemistry
- Nitrosamines -- chemistry
- Pancreatic Neoplasms -- drug therapy
- Proliferating Cell Nuclear Antigen -- chemistry
- Sulfoxides
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.